Oncothyreon Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oncothyreon

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: StockMiser who wrote (591)	4/28/1999 7:49:00 PM
From: Tom Cat	Read Replies (1) of 2344

StockMiser, I am not familiar with the bio-cycle for valuation of bio stocks, mostly being investing on Net and originally in Resource stocks (that are in the dumps). Question I have for you or anyone in this thread is: 1. What are the measuring parameters for the May/15 presentation of results?....what will be considered good/bad/excellent news? 2. Assuming very good news, can we assume a wild run ?...or a gentle slop going north? 3. Sale on the news syndrome....do we expect a sale out on the news if news are not that conclusive? 4. What is the float? How long will the phase III last?.....when do you expect that there will be a green line to market (if succeed of course)? TC

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next